A molecular and staging model predicts survival in patients with resected non-small cell lung cancer

BACKGROUND: The current TNM staging system is far from perfect in predicting the survival of individual non-small cell lung cancer (NSCLC) patients. In this study, we aim to combine clinical variables and molecular biomarkers to develop a prognostic model for patients with NSCLC. METHODS: Candidate...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lei, Shi, Minxin, Wang, Zhiwei, Lu, Haimin, Li, Chang, Tao, Yu, Chen, Xiaoyan, Zhao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180609/
https://www.ncbi.nlm.nih.gov/pubmed/30305064
http://dx.doi.org/10.1186/s12885-018-4881-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180609/
https://www.ncbi.nlm.nih.gov/pubmed/30305064
http://dx.doi.org/10.1186/s12885-018-4881-9

Ejemplares similares